Cargando…
From small studies to precision medicine: prioritizing candidate biomarkers
There are still many open questions in data-analytic research pertaining to biomarker development in the era of personalized/precision medicine and big data. Among them is the question of what constitutes best practice for the extraction of prioritized lists of candidate biomarkers from smaller stud...
Autores principales: | Gaile, Daniel P, Miecznikowski, Jeffrey C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3978446/ https://www.ncbi.nlm.nih.gov/pubmed/24286480 http://dx.doi.org/10.1186/gm507 |
Ejemplares similares
-
Putative null distributions corresponding to tests of differential expression in the Golden Spike dataset are intensity dependent
por: Gaile, Daniel P, et al.
Publicado: (2007) -
Metagenome-wide Association Studies Potentiate Precision Medicine for Rheumatoid Arthritis
por: Tong, Yigang
Publicado: (2015) -
Proteomics promises a new era of precision cancer medicine
por: Wu, Chong, et al.
Publicado: (2019) -
Loss of BAP1 as a candidate predictive biomarker for immunotherapy of mesothelioma
por: Ladanyi, Marc, et al.
Publicado: (2019) -
High-throughput base editing: a promising technology for precision medicine and drug discovery
por: Sachinidis, Agapios
Publicado: (2021)